Skip to search formSkip to main contentSkip to account menu

yttrium Y 90 daclizumab

Known as: Y90 Daclizumab, Y90 MOAB anti-Tac 
A synthetic radioimmunoconjugate comprised of a humanized anti-interleukin-2 (IL-2) antibody linked to the radioisotope Yttrium 90 with potential… 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Daclizumab
NCIt Antineoplastic Agent Terminology

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
KRAS status and survival in multicenter study of RAS mutations (MURAS) in patients with colorectal liver metastases receiving Y90 radioembolization treatment.
239Background: Assessment of the clinical outcome and prognostic factors of patients receiving Y90 radioembolization to treat… 
2018
2018
4:03 PM Abstract No. 268 Role of Y90 radioembolization in BCLC D patients
2017
2017
Does Y90 Radioembolization Prolong Overall Survival Compared With Chemoembolization in Patients With Hepatocellular Carcinoma?
2 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111… 
2016
2016
Improved Cognitive Outcomes in Relapsing-Remitting Multiple Sclerosis with Daclizumab HYP Over 96 Weeks in the Phase 3 DECIDE Study (P3.090)
Objective: Determine daclizumab high-yield process (DAC HYP) efficacy on cognitive outcomes versus intramuscular (IM) interferon… 
2015
2015
Long-Term Efficacy of Daclizumab HYP in Relapsing-Remitting Multiple Sclerosis: 3 Year Results from the SELECTED Extension Study (P7.226)
OBJECTIVE: To assess the efficacy of 150mg subcutaneous daclizumab high-yield process (DAC HYP) after 3 years of treatment in… 
2014
2014
Survival following Y90 radioembolization for neuroendocrine tumor liver metastases: A retrospective, single-center analysis.
e15166 Background: Y90 radioembolization has become an increasingly common palliative measure for patients with unresectable… 
2012
2012
A Randomized, Double-Blind, Placebo-Controlled Study To Evaluate the Safety and Efficacy of Daclizumab HYP Monotherapy in Relapsing-Remitting Multiple Sclerosis: Primary Results of the SELECT Trial…
Review
2012
Review
2012
Embolisation of the Gastroduodenal Artery is Not Necessary in the Presence of Reversed Flow Before Yttrium-90 Radioembolisation
IntroductionThe gastroduodenal artery (GDA) is usually embolised to avoid nontarget dispersal before yttrium-90 (Y90… 
2011
2011
Abstract No. 201: Safety of Y90 radioembolization in patients who have undergone previous external beam radiation therapy
1988
1988
Interstitial irradiation therapy of supratentorial gliomas by stereotaxic technique. Long term results
We report the long term results of interstitial irradiation therapy in patients suffering from malignant supratentorial gliomas… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)